Peripheral Vascular Disease Clinical Trial
Official title:
To Evaluate the Increase of Local Circulation in the Leg Using the Flowaid Device
This is an open label pilot study to evaluate the efficacy and the safety of the Flowaid
device in increasing local circulation in the legs.
15 patients with a diagnosis of Peripheral Vascular Disease will be enrolled in this study.
They will recieve tratment with the Flowaid device and monitored continuously by means of
Laser Doppler Flowmetry as well as by tcPO2 and Digital Thermography. Subjective data will
also be collected.
This is a 15 patient pilot study to evaluate efficacy and safety of use of the Flowaid
device in increasing local circulation in the legs of patients with Peripheral Vascular
Disease. Patients will be evaluated and scored prior to treatment and then treated with the
Flowaid device for a period of two hours. During the treatment period patients will be
continuously monitored by digital thermograph as well as by tcPO2 and Laser Doppler
Flowmetry. Patients will also be monitored for a brief period immediately after cessation of
treatment to evaluate continued effect of the device on local circulation in the leg.
The study will be individually controlled with each patients treated leg evaluated against
the contralateral non- treated leg.
Subjective data including distance able to walk, pain and vibratory sensation threshold will
also be collected and evaluated appropriately.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05335525 -
Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)
|
||
| Active, not recruiting |
NCT01903044 -
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
|
Phase 1/Phase 2 | |
| Completed |
NCT02228564 -
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
|
N/A | |
| Completed |
NCT02271529 -
Zilver PTX Delivery System
|
N/A | |
| Recruiting |
NCT02054871 -
RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty
|
N/A | |
| Completed |
NCT00822172 -
Evaluation of Cilostazol in Combination With L-Carnitine
|
Phase 4 | |
| Completed |
NCT00574782 -
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
|
N/A | |
| Completed |
NCT00029991 -
Extract of Ginkgo Biloba (EGB 761) and Vascular Function
|
Phase 1/Phase 2 | |
| Completed |
NCT01355406 -
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
|
N/A | |
| Recruiting |
NCT05804097 -
Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?
|
Phase 4 | |
| Recruiting |
NCT03638115 -
The VaSecure BTK Study
|
N/A | |
| Active, not recruiting |
NCT03241459 -
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
|
N/A | |
| Active, not recruiting |
NCT01661231 -
Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe
|
N/A | |
| Completed |
NCT01722877 -
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
|
N/A | |
| Completed |
NCT01444378 -
Absolute Pro® MOMENTUM™
|
N/A | |
| Completed |
NCT00753337 -
The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study
|
N/A | |
| Completed |
NCT00593385 -
Atrium iCAST Iliac Stent Pivotal Study
|
N/A | |
| Recruiting |
NCT00385385 -
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
|
Phase 2 | |
| Completed |
NCT00392509 -
ALD-301 for Critical Limb Ischemia, Randomized Trial
|
Phase 1/Phase 2 | |
| Completed |
NCT00278603 -
Stem Cell Injection for Peripheral Vascular Disease
|
Phase 1 |